About the Company
Geron Corporation is a biotechnology company located in Foster City, California owned by Geron Hyn Baja of the Philippines, which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $GERN News
Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future
We feel now is a pretty good time to analyse Geron Corporation's ( NASDAQ:GERN ) business as it appears the company ...
Geron Corp. (GERN) Stock: A Closer Look at the Analyst Ratings
In conclusion, Geron Corp. (GERN) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth ...
The Latest Analyst Ratings For Geron
In the last three months, 8 analysts have published ratings on Geron (NASDAQ:GERN), offering a diverse range of perspectives ...
Geron Stock Is Soaring After Hours: What's Going On?
Geron Corp (NASDAQ:GERN) shares are soaring in Thursday's after-hours session after the company announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee ...
Geron to Participate at Upcoming Investor Conferences in April
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D ...
Geron’s stock soars 95% after FDA advisory panel votes in favor of blood-disorder drug
Geron Corp.’s stock rose 95% Friday, after an advisory panel to the Food and Drug Administration voted 12-to-2 in favor of the company’s blood-disorder drug imetelstat and said its benefits ...
Geron Corp. (GERN) Shares Rise Despite Market Challenges
Based on Geron Corp. (GERN), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -2.02. The debt to equity ratio resting at ...
Geron Stock (NASDAQ:GERN), Analyst Ratings, Price Targets, Predictions
There is no last downgrade for Geron.
Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.
Geron Corp.
What Is a Stock Market Correction? Investors may be shaken by a drop of 10% or more in a stock market index, but corrections are par for the course.
Geron Corp GON
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Loading the latest forecasts...